This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter

Sponsored by Biobeat Technologies Ltd.

About this trial

Last updated 3 years ago

Study ID

CO-002-00

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18 to 120 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 3 years ago

What is this trial about?

Invasive pulmonary capillary wedge pressure measurements using a Swan-Ganz catheter (SGC) is considered the gold standard for cardiac output (CO) monitoring. In this prospective study, we will compare CO measurements between a PPG-based wearable monitor and a SGC in ambulatory CHF patients.

What are the participation requirements?

Yes

Inclusion Criteria

- Patients with CHF

No

Exclusion Criteria

- Pregnant women

- Pediatric patients

- Inability to sign an informed consent form

Locations

Location

Status